Quick Answer
Lactoferrin Supplementation Acne Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Cutibacterium acnes Propionibacterium acnes 6 7 The pathogenesis of acne is multifactorial, arising from the interplay of increased sebum production, abnormal follicular keratinization, colonization with(formerly), and inflammation with contributions from genetic, hormonal, and environmental factors [].
Key Takeaways
- 01Cutibacterium acnes Propionibacterium acnes 6 7 The pathogenesis of acne is multifactorial, arising from the interplay of increased sebum production, abnormal follicular keratinization, colonization with(formerly), and inflammation with contributions from genetic, hormonal, and environmental factors []. [Warp Peyton V. (2026)]
- 02Limited studies of gut microbiota in patients with acne have identified overall reduced diversity, a higher Bacteroidetes:Firmicutes ratio, enrichment of Proteobacteria, depletion of Actinobacteria, and loss of beneficial genera, includingand[–]. [Warp Peyton V. (2026)]
- 03Several studies had unclear risk in selective reporting and performance bias, though outcome data were typically transparent and comprehensive. [Warp Peyton V. (2026)]
- 04The gut–skin axis and human microbiome likely play a role in the pathogenesis of acne vulgaris. [Warp Peyton V. (2026)]
The current Migaku evidence database contains 2 reusable source documents for Lactoferrin Supplementation Acne Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Cutibacterium acnes Propionibacterium acnes 6 7 The pathogenesis of acne is multifactorial, arising from the interplay of increased sebum production, abnormal follicular keratinization, colonization with(formerly), and inflammation with contributions from genetic, hormonal, and environmental factors []. [Warp Peyton V. (2026); evidence level 1]
- Limited studies of gut microbiota in patients with acne have identified overall reduced diversity, a higher Bacteroidetes:Firmicutes ratio, enrichment of Proteobacteria, depletion of Actinobacteria, and loss of beneficial genera, includingand[–]. [Warp Peyton V. (2026); evidence level 1]
- Several studies had unclear risk in selective reporting and performance bias, though outcome data were typically transparent and comprehensive. [Warp Peyton V. (2026); evidence level 1]
- The gut–skin axis and human microbiome likely play a role in the pathogenesis of acne vulgaris. [Warp Peyton V. (2026); evidence level 1]
- We link mechanistic insights with clinical and preclinical evidence and uniquely map molecular functions to dermatologic and trichologic outcomes. [Kaplan N (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources